IP Library Granted Patent US 9,408,845
Granted Patent B2
US 9,408,845 · App. 13/660,671 · Granted Aug 9, 2016

Formulations containing pyridazine compounds

Inventors: D. Martin Watterson (Chicago, IL); Linda Van Eldik (Chicago, IL); Wenhui Hu (Guangzhou, CN)
Assignee: Northwestern University
A61K31/506A61K31/501C07D237/20C07D401/12C07D401/14C07D403/12C07D403/14
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,408,845
App. No.
13/660,671
Granted
Aug 9, 2016
Kind
B2
Abstract

The invention relates to chemical compounds, compositions and methods of making and using the same. In particular, the invention provides selected pyridazine compounds of the formula I wherein R1, R4, R5, R6, R7, R8, R9, R12, R13 ET R14 are independently hydrogen, hydroxyl, alkyl, alkenyl, alkynyl, alkylene, alkenylene, alkoxy, alkenyloxy, cycloalkyl, cycloalkenyl, cycloalkynyl, cycloalkoxy, aryl, aryloxy, arylalkoxy, aroyl, heteroaryl, heterocyclic, acyl, acyloxy, amino, imino, azido, thiol, thioallyl, thioalkoxy, thioaryl, nitro, cyano, halo, sulfate, sulfonyl, sulfinyl, sulfonyl, sultanate, sulfoxide, silyl, silyloxy, silylalkyl, silylthio, ═O, ═S, phosphonate, ureido, carboxyl, carbonyl, carbamoyl, or carboxamide; and X is optionally substituted pyrimidinyl or pyridazinyl, an isomer, a pharmaceutically acceptable salt, or derivative thereof. The invention additional relates to compositions comprising the compounds, and methods of using the compounds and compositions for modulation of cellular pathways, for treatment or prevention of inflammatory diseases, for research, drug screening, and therapeutic applications.

Claims (11)

1. A method of treating a traumatic brain injury in a subject in need of treatment of a traumatic brain injury comprising administering to the subject a composition comprising a compound having the following structure:

or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier, excipient or vehicle.

2. A method of claim 1 , wherein the compound is administered in a dose of 1.0 to 100 mg/kg body weight of the subject.

3. A method of claim 1 , wherein the compound is administered in a dose of 1.0 to 50 mg/kg body weight of the subject.

4. A method of claim 1 , wherein the compound is administered in a dose of 1.0 to 20 mg/kg body weight of the subject.

5. A method of claim 1 , wherein the traumatic brain injury is a closed head injury or a penetrating head injury.

6. A method of claim 1 , wherein the traumatic brain injury is a closed head injury resulting from a hit to the head by a blunt object.

7. A method of claim 1 , wherein the traumatic brain injury is whiplash.

8. A method of claim 1 , wherein the traumatic brain injury is a penetrating head injury resulting from a bullet.

9. A method of claim 1 , wherein the traumatic brain injury comprises secondary damage following an injury.

10. A method of claim 9 , wherein the secondary damage comprises swelling and fluid buildup and the accumulation of the neurotransmitter glutamate.

Assignments (2)
CONFIRMATORY LICENSE Recorded Jan 15, 2013
From: NORTHWESTERN UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029626/0700 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 15, 2013
From: WATTERSON, D. MARTIN; VAN ELDIK, LINDA; HU, WENHUI
To: NORTHWESTERN UNIVERSITY
Reel/Frame 029629/0496 →
Continuity (3)
Continuation 12298652
Provisional Application 60796328 · Apr 28, 2006
Related Publication 20130072496A1 · Mar 21, 2013